The novel treatment of the medication represents a significant development in the handling of type 2 diabetes. Unlike existing therapies, tirzepatide targets dual pathways – the GLP-1 hormone and GIP – resulting in https://tirzepatidepeptide411890.amoblog.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-64142043